Clinical Trial Update: Hemostasis in Patients With Idiopathic Thrombocytopenic Purpura

View source ↗

Summary

A completed clinical trial (NCT01571349) from Samsung Medical Center evaluating hemostasis in patients with idiopathic thrombocytopenic purpura.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Thrombocytopenic Purpura

Snippet

Sponsor: Samsung Medical Center | Conditions: Idiopathic Thrombocytopenic Purpura | Status: COMPLETED